159 related articles for article (PubMed ID: 34290791)
1. Associations between dialysate interleukin-6 and Tie-2 and peritoneal solute transport rate and outcomes for patients undergoing peritoneal dialysis: A prospective cohort study.
Hang Y; Yan H; Zhang H; Li Z; Fang W
Pak J Med Sci; 2021; 37(4):1104-1110. PubMed ID: 34290791
[TBL] [Abstract][Full Text] [Related]
2. Plasma and dialysate IL-6 and VEGF concentrations are associated with high peritoneal solute transport rate.
Pecoits-Filho R; Araújo MR; Lindholm B; Stenvinkel P; Abensur H; Romão JE; Marcondes M; De Oliveira AH; Noronha IL
Nephrol Dial Transplant; 2002 Aug; 17(8):1480-6. PubMed ID: 12147798
[TBL] [Abstract][Full Text] [Related]
3. Systemic and intraperitoneal interleukin-6 system during the first year of peritoneal dialysis.
Pecoits-Filho R; Carvalho MJ; Stenvinkel P; Lindholm B; Heimbürger O
Perit Dial Int; 2006; 26(1):53-63. PubMed ID: 16538876
[TBL] [Abstract][Full Text] [Related]
4. Cytokine profiles in peritoneal dialysis effluent predicts the peritoneal solute transport rate in continuous ambulatory peritoneal dialysis patients.
Zhou L; Wen F; Chen G; Liu J; Liu H; Peng Y; Cheng M; Liu Y; Zhang H; Liu Y
Int J Clin Exp Med; 2015; 8(11):20424-33. PubMed ID: 26884958
[TBL] [Abstract][Full Text] [Related]
5. Intraperitoneal interleukin-6 levels predict peritoneal solute transport rate: a prospective cohort study.
Yang X; Zhang H; Hang Y; Yan H; Lin A; Huang J; Ni Z; Qian J; Fang W
Am J Nephrol; 2014; 39(6):459-65. PubMed ID: 24854010
[TBL] [Abstract][Full Text] [Related]
6. Can the inflammation markers of patients with high peritoneal permeability on continuous ambulatory peritoneal dialysis be reduced on nocturnal intermittent peritoneal dialysis?
Cueto-Manzano AM; Rojas-Campos E; Martínez-Ramírez HR; Valera-González I; Medina M; Monteón F; Ruiz N; Becerra M; Palomeque MA; Cortés-Sanabria L
Perit Dial Int; 2006; 26(3):341-8. PubMed ID: 16722027
[TBL] [Abstract][Full Text] [Related]
7. Selected growth factors in peritoneal dialysis: their relationship to markers of inflammation, dialysis adequacy, residual renal function, and peritoneal membrane transport.
Stompór T; Zdzienicka A; Motyka M; Dembińska-Kieć A; Davies SJ; Sulowicz W
Perit Dial Int; 2002; 22(6):670-6. PubMed ID: 12556068
[TBL] [Abstract][Full Text] [Related]
8. Dialysate cell-free mitochondrial DNA fragments as a marker of intraperitoneal inflammation and peritoneal solute transport rate in peritoneal dialysis.
Xie X; Wang J; Xiang S; Chen Z; Zhang X; Chen J
BMC Nephrol; 2019 Apr; 20(1):128. PubMed ID: 30975091
[TBL] [Abstract][Full Text] [Related]
9. Does a high peritoneal transport rate reflect a state of chronic inflammation?
Wang T; Heimbürger O; Cheng HH; Bergström J; Lindholm B
Perit Dial Int; 1999; 19(1):17-22. PubMed ID: 10201336
[TBL] [Abstract][Full Text] [Related]
10. Influence of peritoneal transport rate, inflammation, and fluid removal on nutritional status and clinical outcome in prevalent peritoneal dialysis patients.
Chung SH; Heimbürger O; Stenvinkel P; Wang T; Lindholm B
Perit Dial Int; 2003; 23(2):174-83. PubMed ID: 12713086
[TBL] [Abstract][Full Text] [Related]
11. Intra-peritoneal interleukin-6 system is a potent determinant of the baseline peritoneal solute transport in incident peritoneal dialysis patients.
Oh KH; Jung JY; Yoon MO; Song A; Lee H; Ro H; Hwang YH; Kim DK; Margetts P; Ahn C
Nephrol Dial Transplant; 2010 May; 25(5):1639-46. PubMed ID: 20061317
[TBL] [Abstract][Full Text] [Related]
12. Dialysate interleukin-6 predicts increasing peritoneal solute transport rate in incident peritoneal dialysis patients.
Cho Y; Johnson DW; Vesey DA; Hawley CM; Pascoe EM; Clarke M; Topley N;
BMC Nephrol; 2014 Jan; 15():8. PubMed ID: 24410736
[TBL] [Abstract][Full Text] [Related]
13. Peritoneal transport status influence on atherosclerosis/inflammation in CAPD patients.
Sezer S; Tutal E; Arat Z; Akçay A; Celik H; Ozdemir FN; Haberal M
J Ren Nutr; 2005 Oct; 15(4):427-34. PubMed ID: 16198934
[TBL] [Abstract][Full Text] [Related]
14. Dialysate copeptin and peritoneal transport in incident peritoneal dialysis patients.
Fijałkowski M; Safranow K; Lindholm B; Ciechanowski K; Muraszko AM; Dołęgowska B; Dołęgowska K; Golembiewska E
Int Urol Nephrol; 2019 Sep; 51(9):1667-1673. PubMed ID: 31187425
[TBL] [Abstract][Full Text] [Related]
15. Relationship between peritoneal solute transport and dialysate inflammatory markers in peritoneal dialysis patients: A cross-sectional study.
Li XR; Yang SK; Zeng BY; Tian J; Liu W; Liao XC
Nefrologia (Engl Ed); 2023; 43(3):335-343. PubMed ID: 36517360
[TBL] [Abstract][Full Text] [Related]
16. Association between an increased surface area of peritoneal microvessels and a high peritoneal solute transport rate.
Numata M; Nakayama M; Nimura S; Kawakami M; Lindholm B; Kawaguchi Y
Perit Dial Int; 2003; 23(2):116-22. PubMed ID: 12713076
[TBL] [Abstract][Full Text] [Related]
17. Neutral-pH peritoneal dialysis solution improves peritoneal function and decreases matrix metalloproteinase-2 (MMP-2) in patients undergoing continuous ambulatory peritoneal dialysis (CAPD).
Nishina M; Endoh M; Suzuki D; Tanabe R; Endoh H; Hirahara I; Sakai H
Clin Exp Nephrol; 2004 Dec; 8(4):339-43. PubMed ID: 15619033
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of peritoneal transport and membrane status in peritoneal dialysis: focus on incident fast transporters.
Rodrigues AS; Martins M; Korevaar JC; Silva S; Oliveira JC; Cabrita A; Castro e Melo J; Krediet RT
Am J Nephrol; 2007; 27(1):84-91. PubMed ID: 17284895
[TBL] [Abstract][Full Text] [Related]
19. Benefits of a continuous ambulatory peritoneal dialysis (CAPD) technique with one icodextrin-containing and two biocompatible glucose-containing dialysates for preservation of residual renal function and biocompatibility in incident CAPD patients.
Yoon HE; Chang YK; Shin SJ; Choi BS; Kim BS; Park CW; Song HC; Yoon SA; Jin DC; Kim YS
J Korean Med Sci; 2014 Sep; 29(9):1217-25. PubMed ID: 25246739
[TBL] [Abstract][Full Text] [Related]
20. Dialysate to plasma solute concentration (D/P) versus peritoneal transport parameters in CAPD.
Heimbürger O; Waniewski J; Werynski A; Park MS; Lindholm B
Nephrol Dial Transplant; 1994; 9(1):47-59. PubMed ID: 8177476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
